James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 1,294 shares at $94.57 ($122K) on 2024-02-29, disclosed to the SEC on 2024-03-01.
Scheduled sale ($122k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.57 | 647 | $61K | 50.0% |
| 2 | $94.57 | 647 | $61K | 50.0% |
| Total | $94.57 avg | 1,294 | $122K | 100% |
| Filing → |
| MRNA | SELL | 2024-10-08 | $43K | — | Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |